Furosemide Injection, Solution
Product Images NDC 0409-6102

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Furosemide (NDC 0409-6102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Furosemide Structural Formula (Furosemide 01)

Chemical structure diagram of furosemide, showing its molecular framework including a chlorinated benzene ring, sulfonamide group, and a furanyl substituent, consistent with the active ingredient in FUROSEMIDE injection solution.*

FDA Label Image

Novaplus Logo (Furosemide 02)

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Furosemide Injection USP 10 mg/mL in 2 mL volume, with total 20 mg per 2 mL dose. The label includes NDC 0409-6102-35 and indicates prescription use only. Distributed by Hospira, Inc., Lake Forest, IL. The label also features a barcode, lot number, and expiration date placeholders.*

FDA Label Image

Principal Display Panel (2 mL Vial Tray)

The packaging label for Furosemide Injection USP, 20 mg/2 mL (10 mg/mL) single-dose vials. It is indicated for intravenous or intramuscular use and is distributed by Hospira, Inc. The label includes storage instructions and ingredient information. The product is made in Italy and features a barcode and trademark for Novaplus.*

FDA Label Image

Principal Display Panel (4 mL Vial Label)

Label for Furosemide Injection, USP 40 mg/4 mL (10 mg/mL) solution in a 4 mL single-dose vial. The label indicates the product is for intravenous or intramuscular use, distributed by Hospira, Inc., Lake Forest, IL. The NDC is 0409-6102-36. It includes a barcode, lot and expiration date placeholders, and a note to not use if discolored or containing particulates.*

FDA Label Image

Principal Display Panel (4 mL Vial Tray)

Packaging label for Furosemide Injection USP, 40 mg/4 mL (10 mg/mL) solution for injection. The label indicates single-dose 4 mL vials intended for intravenous or intramuscular use. The labeler is Hospira, Inc., with Novaplus marking. The label includes handling instructions and lot identification areas.*

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Label for Furosemide Injection, USP 10 mg/mL (100 mg/10 mL) single-dose vial. The label indicates use for intravenous or intramuscular injection. Distributed by Hospira, Inc., Lake Forest, IL. Includes dosage strength, route of administration, and lot/expiration placeholders.*

FDA Label Image

Principal Display Panel (10 mL Vial Tray)

Label for Furosemide Injection, USP 10 mg/mL (100 mg/10 mL) single-dose vial, indicated for intravenous or intramuscular use. The label shows the Hospira, Inc. distributor and Novaplus branding. It includes NDC codes 0409-6102-27 and 0409-6102-37, storage instructions, and dosage form as injection solution in 10 mL vials with 25 vials per package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.